Supply of Srph153042-Coronary Drug Eluting Stents With 1 Stent On Cobalt Chromi Um Alloy Or Platinum Chromium Alloy. 2 Stent With Coating Of Polymer Carrier For Active Drug Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preven Ting Neo-Intimal Hyperplasia 3 Stent Diameter Should Be From 2.5Mm To 4Mm . The Le Ngth Of The Stent Should Be 12 To 48Mm . 4 The Strut Thickness Should Be 91 Micron Or Less. 5 Stent Delivery System Should Be Monorail Single Operator Exchange Or Rapid Exchange. 6 Stent Should Be Compatible With 5Fr Guiding Catheter 7 Stent D Esign Should Be Open Cell Type. 8 Stent Should Be Approved By Dcgi. The Copy Of Dc Gi Approval Should Be Enclosed In The Tender Bid / Offer. 9 The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis Isr And In-Situ Thrombosi S Ist Should Be Documented / Published In Peer Reviewed Scientific Journals. 10The Manufacturer/Supplier Should Submit Proof Of Supply Of The Stent To A Major Gov Ernment Institute.Bis Standards For The Drug Eluting Stent Are Not Available Refe Rence : Bis Catalogue Unit: No.
Supply of 720 Sirolimus Coated Drug Eluting Coronary Stent Q3
Supply Of Medicines-Tab Certinib 150 Mg, Tab Temozolamide 250 Mg, Tab Cilostazole 50 Mg, Tab Deferasirox 500 Mg, Tab Doxepin 25 Mg, Tab Desmopressin, Tab Diltiazem 30 Mg, Tab Diltiazem 60 Mg, Tab Eltrombopag 50 Mg, Tab Escitalopram 10 Mg, Tab. Levosulbutamol Solution 0.31 Mcg, Tab Misoprostol 200 Mcg, Tab Nintedanib 100 Mg, Tab Sirolimus 1 Mg, Tab Sulfasalazine, Tab Salbutamol Sulphate, Salbutamol Respules Solution 15 Ml, Tab Everolimus 0.25 Mg, Tab Pioglitazone 15 Mg, Cm Eye Applicap, Tab Ondansetron , Tab Trypsin/Chymotrypsin, Oint. Mupirocin 20 Gm Tube, Oint Lignocaine 2%, Tab Isosorbide S Mononitrate Sr 30 Mg, Tab Clobazam 10 Mg
